Filters
Country
When published
Type
Sector
Notices by category
Un Motol - Tilldrakizumab 200 Mg
| Buyer : Fakultní nemocnice v Motole | |
| Create/Change Date : 2025-04-30 03:29:24 | Countries : [Czech Republic] |
| Deadline : 2025-05-30 00:00:00 | Type : Invitation for Bids |
| Original Language : cs | |
| Estimated Value : 16207818 EUR | View Details |
Delivery Of Medicinal Products To Drug Programs, Various Medicines, Medical Devices And Various Products
| Buyer : Dolnośląski Szpital Specjalistyczny im. T.Marciniaka Centrum Medycyny Ratunkowej | |
| Create/Change Date : 2025-04-29 09:27:35 | Countries : [Poland] |
| Deadline : 2025-06-04 00:00:00 | Type : Invitation for Bids |
| Original Language : Polski | |
| Estimated Value : 0 | View Details |
Drug Supply - The Active Substance Baricitinib - Atc L04Af02
| Buyer : Fakultní Thomayerova nemocnice | |
| Create/Change Date : 2025-04-29 15:28:59 | Countries : [Czech Republic] |
| Deadline : 2025-05-30 00:00:00 | Type : Invitation for Bids |
| Original Language : cs | |
| Estimated Value : 0 | View Details |
Purchase Medicines 1-2025
| Buyer : SPITALUL CLINIC DR. I. CANTACUZINO | |
| Create/Change Date : 2025-04-30 03:32:08 | Countries : [Romania] |
| Deadline : 2025-06-06 00:00:00 | Type : Invitation for Bids |
| Original Language : Romanian | |
| Estimated Value : 15921746 RON | View Details |
Lp Containing Adalimumab 2025
| Buyer : Fakultní nemocnice Olomouc | |
| Create/Change Date : 2025-04-28 09:37:25 | Countries : [Czech Republic] |
| Deadline : 2025-05-30 00:00:00 | Type : Invitation for Bids |
| Original Language : cs | |
| Estimated Value : 7780228 EUR | View Details |
Selective Immunosuppressants - Imlifidasa Ii.
| Buyer : Institut klinické a experimentální medicíny | |
| Create/Change Date : 2025-04-28 22:28:38 | Countries : [Czech Republic] |
| Deadline : 2025-05-27 00:00:00 | Type : Invitation for Bids |
| Original Language : cs | |
| Estimated Value : 143500000 EUR | View Details |
Selective Immunosuppressants - Imlifidasa Ii.
| Buyer : Institut klinické a experimentální medicíny | |
| Create/Change Date : 2025-04-29 03:27:13 | Countries : [Czech Republic] |
| Deadline : 2025-05-27 00:00:00 | Type : Invitation for Bids |
| Original Language : cs | |
| Estimated Value : 143500000 CZK | View Details |
Atc Drugs L04Ag03
| Buyer : Všeobecná zdravotná poisťovňa, a.s. | |
| Create/Change Date : 2025-04-22 15:39:42 | Countries : [Slovakia] |
| Deadline : 2025-05-07 00:00:00 | Type : Invitation for Bids |
| Original Language : Slovak | |
| Estimated Value : 0 EUR | View Details |
Atc Drugs L04Ag03
| Buyer : Úrad pre verejné obstarávanie | |
| Create/Change Date : 2025-04-16 09:39:27 | Countries : [Slovakia] |
| Deadline : 2025-05-16 00:00:00 | Type : Invitation for Bids |
| Original Language : Slovak | |
| Estimated Value : 0 | View Details |
Lp Containing Anagrelide 2025
| Buyer : Fakultní nemocnice Olomouc | |
| Create/Change Date : 2025-04-15 03:38:24 | Countries : [Czech Republic] |
| Deadline : 2025-05-19 00:00:00 | Type : Invitation for Bids |
| Original Language : cs | |
| Estimated Value : 2966457 EUR | View Details |
Atc Drugs L04Ag03
33652300-8
| Buyer : Všeobecná zdravotná poisťovňa, a.s. | |
| Create/Change Date : 2025-04-16 15:41:25 | Countries : [Slovakia] |
| Deadline : 2025-05-16 00:00:00 | Type : Invitation for Bids |
| Original Language : Slovak | |
| Estimated Value : 11458608 EUR | View Details |
Medicinal Products Containing Risankizumab, Tofacitinib, Aprremilast, Mirikizumab, Deukravacitinib, Voclosporin, Siltuximab
| Buyer : Fakultní nemocnice Hradec Králové | |
| Create/Change Date : 2025-04-08 03:35:51 | Countries : [Czech Republic] |
| Deadline : 2025-05-06 00:00:00 | Type : Invitation for Bids |
| Original Language : cs | |
| Estimated Value : 0 | View Details |
Drug Supply - The Active Substance Kladribin - Atc L04Aa40
| Buyer : Fakultní Thomayerova nemocnice | |
| Create/Change Date : 2025-04-02 21:33:20 | Countries : [Czech Republic] |
| Deadline : 2025-05-05 00:00:00 | Type : Invitation for Bids |
| Original Language : cs | |
| Estimated Value : 0 | View Details |
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
| Buyer : Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad | |
| Create/Change Date : 2024-12-30 08:35:41 | Countries : [Spain] |
| Deadline : 2025-10-01 00:00:00 | Type : Invitation for Bids |
| Original Language : Spanish | |
| Estimated Value : 402393949 EUR | View Details |
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
| Buyer : Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad | |
| Create/Change Date : 2024-12-30 02:35:29 | Countries : [Spain] |
| Deadline : 2025-10-01 00:00:00 | Type : Invitation for Bids |
| Original Language : Spanish | |
| Estimated Value : 402393949 EUR | View Details |
The Medicine Ravulizumab
| Buyer : Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos | |
| Create/Change Date : 2024-10-15 16:39:32 | Countries : [Lithuania] |
| Deadline : 2025-10-15 00:00:00 | Type : Procurement Plan |
| Original Language : Lithuanian | |
| Estimated Value : 295244 EUR | View Details |